Ritholtz Wealth Management’s United Therapeutics UTHR Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$653K	Sell	1,102 -28	-2%	-$13.9K	0.01%	693
2025 Q4	$551K	Buy	1,130 +168	+17%	+$78.2K	0.01%	691
2025 Q3	$403K	Sell	962 -113	-11%	-$38K	0.01%	744
2025 Q2	$309K	Buy	1,075 +250	+30%	+$74.7K	0.01%	784
2025 Q1	$254K	Hold	825	–	–	0.01%	792
2024 Q4	$291K	Sell	825 -14	-2%	-$5.15K	0.01%	717
2024 Q3	$301K	Buy	839 +105	+14%	+$35.5K	0.01%	699
2024 Q2	$234K	Buy	+734	New	+$194K	0.01%	724
2023 Q1	–	Sell	-1,026	Closed	-$285K	–	672
2022 Q4	$285K	Sell	1,026 -267	-21%	-$67.4K	0.02%	465
2022 Q3	$271K	Buy	1,293 +120	+10%	+$26.8K	0.01%	574
2022 Q2	$276K	Sell	1,173 -250	-18%	-$50.8K	0.02%	429
2022 Q1	$255K	Sell	1,423 -1,237	-47%	-$236K	0.02%	447
2021 Q4	$575K	Buy	2,660 +67	+3%	+$13.2K	0.04%	271
2021 Q3	$479K	Buy	2,593 +517	+25%	+$102K	0.03%	279
2021 Q2	$372K	Buy	2,076 +508	+32%	+$96.8K	0.03%	322
2021 Q1	$262K	Buy	+1,568	New	+$261K	0.02%	345